Deals & business · first seen 1h ago, updated 1h ago
Travere CEO Eric Dube on deciding to leave; Roche tees up a board seat for ex-Takeda chief
On Dec. 1, Travere Therapeutics will have a new CEO for the first time in almost eight years, as Eric Dube hands the baton to former Amicus Therapeutics CEO Bradley Campbell. The commercial-stage rare disease ...
Summary from Endpoints News.